Immatics IMTX
NASDAQ IMTX
$9.56 +0.10 (+1.06%)
As of: Sep 4, 2026 · 3:59 PM EDT

Immatics (IMTX) Enterprise Value (2019 - 2026)

Immatics (IMTX) posted Enterprise Value of -$546.3 million for Q4 2025, down 8.47% sequentially from -$503.7 million in Q3 2025, and up 15.42% YoY from -$473.3 million in Q4 2024.

Analysis

Immatics (IMTX) Enterprise Value (2019 - 2026) Analysis & Trends

Immatics has reported Enterprise Value for 7 years, with the latest figure at -$546.3 million in Q4 2025.

  • Quarterly Enterprise Value rose 15.42% year-over-year to -$546.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$546.3 million (up 15.42% YoY) and the FY2025 annual result came in at -$530.3 million, up 18.95% from the prior year.
  • Enterprise Value fell to -$546.3 million in Q4 2025 per IMTX's latest filing, from -$503.7 million in the prior quarter.
  • Over five years, Enterprise Value peaked at -$166.0 million in Q4 2021 and troughed at -$645.9 million in Q4 2024.
  • A 5-year average of -$415.8 million and a median of -$398.4 million in 2023 frame the typical range for Enterprise Value.
  • The widest YoY moves for Enterprise Value: up 39.98% in 2021, down 146.41% in 2021.
  • Over 5 years, Enterprise Value stood at -$166.0 million in 2021, then sank by 122.6% to -$369.5 million in 2022, then retreated by 24.0% to -$458.2 million in 2023, then slumped by 40.96% to -$645.9 million in 2024, then increased by 15.42% to -$546.3 million in 2025.
  • According to Business Quant data, Enterprise Value over the past three periods registered -$546.3 million, -$503.7 million, and -$541.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Immatics 1.17 Bn 711.21 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 900.93 Mn
Mar 31, 2026 788.25 Mn
Dec 31, 2025 861.42 Mn
Sep 30, 2025 531.94 Mn
Jun 30, 2025 112.65 Mn
Mar 31, 2025 -23.78 Mn
Dec 31, 2024 218.31 Mn
Sep 30, 2024 637.76 Mn
Jun 30, 2024 625.75 Mn
Mar 31, 2024 425.11 Mn
Dec 31, 2023 433.21 Mn
Sep 30, 2023 489.40 Mn
Jun 30, 2023 506.24 Mn
Mar 31, 2023 175.03 Mn
Dec 31, 2022 298.26 Mn
Sep 30, 2022 317.37 Mn
Jun 30, 2022 201.96 Mn
Mar 31, 2022 219.12 Mn
Dec 31, 2021 679.73 Mn
Sep 30, 2021 419.75 Mn